Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Dhingra

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
American Journal of Clinical Oncology|June 1, 1984
Phase II clinical evaluation of dihydroxyanthracenedione in patients with advanced lung cancerM Valdivieso, T Umsawasdi, G Spitzer, et al.
American Journal of Clinical Oncology|June 1, 1992
Phase II study of combination therapy with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small-cell lung cancerD M Shin, H M Dhingra, J S Lee, et al.
Cancer Treatment Reports|May 1, 1986
Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancerH M Dhingra, T Umsawasdi, D F Chiuten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancerH M Dhingra, M Valdivieso, D T Carr, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Intrapleural etoposide for malignant effusionP Y Holoye, D G Jeffries, H M Dhingra, et al.
Cancer Treatment Reports|June 1, 1986
Combination chemotherapy with vindesine and cisplatin for refractory small cell bronchogenic carcinomaD F Chiuten, D T Carr, H M Dhingra, et al.
Cancer Treatment Reports|July 1, 1985
Phase II clinical trial of diaziquone in bronchogenic carcinomaD F Chiuten, T Umsawasdi, H M Dhingra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1986
High-dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinomaG Spitzer, P Farha, M Valdivieso, et al.
American Journal of Clinical Oncology|December 1, 1987
Phase II pilot study with cisplatin, etoposide, and continuous-infusion 5-fluorouracil in metastatic non-small cell lung cancerJ S Lee, H M Dhingra, D F Chiuten, et al.
Investigational New Drugs|September 1, 1988
Phase II study of tiazofurin (NSC 286193) in the treatment of advanced small cell bronchogenic carcinomaP Y Holoye, D T Carr, H M Dhingra, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
American Journal of Clinical Oncology|June 1, 1984
Phase II clinical evaluation of dihydroxyanthracenedione in patients with advanced lung cancerM Valdivieso, T Umsawasdi, G Spitzer, et al.
American Journal of Clinical Oncology|June 1, 1992
Phase II study of combination therapy with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small-cell lung cancerD M Shin, H M Dhingra, J S Lee, et al.
Cancer Treatment Reports|May 1, 1986
Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancerH M Dhingra, T Umsawasdi, D F Chiuten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancerH M Dhingra, M Valdivieso, D T Carr, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Intrapleural etoposide for malignant effusionP Y Holoye, D G Jeffries, H M Dhingra, et al.
Cancer Treatment Reports|June 1, 1986
Combination chemotherapy with vindesine and cisplatin for refractory small cell bronchogenic carcinomaD F Chiuten, D T Carr, H M Dhingra, et al.
Cancer Treatment Reports|July 1, 1985
Phase II clinical trial of diaziquone in bronchogenic carcinomaD F Chiuten, T Umsawasdi, H M Dhingra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1986
High-dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinomaG Spitzer, P Farha, M Valdivieso, et al.
American Journal of Clinical Oncology|December 1, 1987
Phase II pilot study with cisplatin, etoposide, and continuous-infusion 5-fluorouracil in metastatic non-small cell lung cancerJ S Lee, H M Dhingra, D F Chiuten, et al.
Investigational New Drugs|September 1, 1988
Phase II study of tiazofurin (NSC 286193) in the treatment of advanced small cell bronchogenic carcinomaP Y Holoye, D T Carr, H M Dhingra, et al.
Pageof 3